Also trades as: CERO (OTC) · $vol 0M
CEROW OTC
CERo Therapeutics Holdings, Inc.
1W: +20.0%
1M: -66.7%
3M: -80.0%
YTD: -40.0%
1Y: -62.0%
$0.00
-0.00 (-21.01%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.003-0.003
Volume10,000
Avg Volume116,366
Beta1.37
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher Ehrlich
Employees8
SectorHealthcare
IndustryBiotechnology
IPO Date2024-02-14
Websitecero.bio
201 Haskins Way
South San Francisco, CA 94080
US
South San Francisco, CA 94080
US
650-407-2376
About CERo Therapeutics Holdings, Inc.
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Francois Eric | 0 | — | 2026-02-13 | |
| Patel Shami | 0 | — | 2024-10-11 | |
| Patel Shami | 0 | — | 2024-10-11 | |
| KUCHARCHUK ANDREW AL | 0 | — | 2024-10-01 | |
| Pierce Kristen | 0 | — | 2024-10-01 |